Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate antitrust subcommittee health care agenda

Executive Summary

Rx industry competition issues will be examined by Senate Judiciary/Antitrust, Competition Policy & Consumer Rights Subcommittee in 2003, subcommittee Chairman Mike DeWine (R-Ohio) announces. Committee will focus on "the state of competition in the prescription drug industry to ensure that consumers benefit from vigorous competition in the prescription drug market," agenda says. Subcommittee also plans continued inquiry into group purchasing organizations' "reforms to their business practices" (1"The Pink Sheet" May 13, 2002, p. 18)...

You may also be interested in...

GPO Self-Regulation Prescribed As Alternative To Congressional Action

GPO conflicts-of-interest will be one topic addressed by a group purchasing organization working group formed at the behest of Senate Judiciary/Antitrust Subcommittee Chairman Herbert Kohl (D-Wisc.)

Common Regulatory Starting Point Means EU-UK Are On Track For Medtech MRA, Say German Firms

With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.

COVID-19 Vaccines Donated To Philippines Require Emergency Use Authorization

Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts